Clinical Trials Directory

Trials / Terminated

TerminatedNCT04815018

Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2

A Longitudinal Observational Study Identifying Shifts in the Respiratory Microbiome and Clinical Outcomes of SARS-CoV-2 in Nursing Home Residents

Status
Terminated
Phase
Study type
Observational
Enrollment
185 (actual)
Sponsor
Pathnostics · Industry
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

This is a longitudinal, prospective observational study focusing on health-related outcomes relative to potential changes in the respiratory microbiome seen with weekly SARS-CoV-2 testing in nursing home residents.

Detailed description

This study targets the influence of SARS-CoV-2, and the presence of mixed/co-infections on the respiratory microbiome. Their interrelationship will be characterized in a prospective observational study design. The observed changes will be correlated to medical (FEV1, CXR/CT, mortality, morbidity, symptoms) and clinical laboratory parameters (hematology, coagulation, bacterial/viral detection). The study aims at the detection of significant changes in microbiome in the respiratory tract following incidence of SARS-CoV-2 infection. These alterations in the respiratory microbiome will be determined by shotgun metagenomic sequencing. Ultimately, this can provide a better understanding of how SARS-CoV-2 and the presence of other bacteria and viruses affect the composition of the respiratory microbiome and a description of the microbiological etiology of these respiratory tract infections.

Conditions

Timeline

Start date
2020-10-07
Primary completion
2021-05-30
Completion
2021-05-30
First posted
2021-03-24
Last updated
2021-06-30

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04815018. Inclusion in this directory is not an endorsement.